San Francisco, CA, United States of America

Michael Mann



 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Michael Mann in Cancer Treatment

Introduction: Michael Mann, an accomplished inventor based in San Francisco, CA, has made significant strides in the field of oncology through his innovative research and patent contributions. With five patents to his name, Mann is dedicated to advancing medical treatments that aim to alleviate the burden of cancer and related conditions.

Latest Patents: Among Mann's latest patents are groundbreaking compounds and compositions designed for the treatment of cancer and fibrosis. His disclosures include pharmaceutical compositions that feature pyrazolyl-containing compounds, as well as their derivatives. These innovative formulations hold promise for improving therapeutic options in oncology, reflecting Mann's commitment to enhancing patient care through science.

Career Highlights: Throughout his career, Mann has been affiliated with prestigious institutions such as the University of California, where he contributed to pivotal research initiatives. His journey also includes significant contributions to Encore Clinical, Inc., where his work focused on developing novel treatment strategies in the medical field.

Collaborations: Mann has worked alongside esteemed colleagues such as David Jablons and Biao He. These collaborations have fostered an environment of shared knowledge and innovation, enhancing the potential for transformative advancements in cancer treatment.

Conclusion: Michael Mann's dedication to inventing new therapeutic solutions exemplifies the spirit of innovation in the fight against cancer. As he continues to develop cutting-edge compounds and compositions, his work remains vital to the ongoing quest for effective treatments and improved patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…